Advertisement
Combining dual inhibition with anti-PD1 therapy yielded >60% rate of complete tumor regression
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
Understanding the role of patient sex may lead to personalized therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement